March 26th 2021
Experts focus in on optimizing the use of minimal residual disease as a tool to guide decision making in the adjuvant setting for patients at risk for recurrence with colorectal cancer.
January 21st 2021
CancerNetwork spoke with Kenneth C. Anderson, MD, about treatment advances in myeloma - from smoldering, newly diagnosed, and relapsed/refractory multiple myeloma.
January 13th 2021
CancerNetwork spoke with Wade T. Iams, MD, about treatment options available and being evaluated in small cell lung cancer.